Nikolaos Thomakos1, Sofia-Paraskevi Trachana1, Michalis Liontos2, Aristotelis Bamias2, Alexandros Rodolakis1
1First Department of Obstetrics and Gynecology, Division of Gynecological Oncology, National and Kapodistrian University of Athens, Alexandra General Hospital, Athens, Greece
2Department of Clinical Therapeutics, National and Kapodistrian University of Athens, Alexandra General Hospital, Athens, Greece
Correspondence: Dr. Nikolaos Thomakos, MD, Ph.D, Consultant in Obstetrics and Gynecology. “Alexandra General Hospital”, First Department of Obstetrics and Gynecology, 80 Vas. Sofias Av. 11528, Athens, Greece, E – mail: firstname.lastname@example.org
Cervical cancer is one of the most popular and lethal gynecological cancers worldwide. The standard treatment for early stage cervical cancer is radical hysterectomy combined with bilateral pelvic lymph node assessment. The infertility and the serious complications follow the radical hysterectomy, has lead gynecologic-oncologists to revise radical surgical approaches, in order to preserve fertility without increasing the risk of recurrence and mortality. The safety and feasibility of less radical surgery, such as radical trachelectomy, has been clearly demonstrated while the oncologic outcomes support that radical trachelectomy is suitable for low risk early stage cervical cancer patients wishing to preserve fertility.
Keywords: trachelectomy, cervical; cancer, fertility, preservation